What Is Strattera?

Strattera is the brand name for atomoxetine, a non-stimulant medication approved by the FDA in 2002 for the treatment of ADHD in children, adolescents, and adults. It was the first non-stimulant ADHD medication approved in the United States, and it remains one of the most commonly prescribed alternatives when stimulant medications aren't the right fit.

Unlike Adderall or Ritalin, Strattera is not a controlled substance. It works through a completely different mechanism than stimulant medications, which affects both who benefits from it and what the experience of taking it is like.

How Strattera Works

Strattera is a selective norepinephrine reuptake inhibitor (NRI). It increases the availability of norepinephrine in the brain's prefrontal cortex, the region most closely tied to attention, impulse control, and working memory. By blocking the transporter that normally removes norepinephrine from synapses, Strattera allows the neurotransmitter to stay active longer.

This differs from stimulant medications, which primarily act on dopamine. The dopamine system handles reward, motivation, and the sense of urgency that people with ADHD often can't generate on their own. Norepinephrine, by contrast, plays a bigger role in sustained attention and emotional regulation. This distinction matters because some people respond better to one system versus the other, and some benefit when both are addressed together.

One important note on timing: Strattera is not a fast-acting medication. Most people don't notice significant changes until two to four weeks into treatment, with full effects sometimes taking six to eight weeks. This slow onset is one of its sharpest differences from stimulants, which typically work within 30 to 60 minutes.

Who Strattera Is For

Strattera tends to work well for people in specific situations where stimulants are less appropriate or less effective.

People who can't tolerate stimulant side effects often do better on Strattera. If Adderall or Ritalin causes significant anxiety, a faster heart rate, insomnia, or appetite suppression that doesn't improve with dose adjustments, Strattera offers a path to ADHD treatment without those particular trade-offs.

ADHD with comorbid anxiety is another area where Strattera gets attention. Stimulants can worsen anxiety in some people; Strattera typically doesn't, and some patients report mild anxiety reduction alongside ADHD symptom improvement. The evidence here is mixed, but it's a real clinical consideration.

People with a history of substance use disorder may be good candidates too. Strattera has no abuse potential and is not scheduled, which makes it appropriate when stimulant medications raise concerns. Similarly, those with tic disorders (which stimulants can worsen) sometimes do better with a non-stimulant option.

Strattera vs Stimulants: Key Differences

The choice between Strattera and stimulants isn't straightforward, and most physicians consider it based on a person's specific symptom profile, other conditions, lifestyle, and prior medication history.

Stimulants generally show stronger and faster symptom reduction in head-to-head studies. Strattera's effectiveness is well-documented, but its average effect size is typically smaller than that of first-line stimulants. For people with moderate to severe ADHD who respond to stimulants, the stimulant is usually the first choice.

Where Strattera stands out is coverage and consistency. It provides 24-hour symptom coverage from a single daily dose, with no "wearing off" periods in the late afternoon or evening that are common with extended-release stimulants. Some adults find this particularly useful for time management throughout the day and for keeping ADHD managed during evening hours when stimulant coverage typically drops.

Strattera also doesn't cause rebound effects when it wears off. The gradual onset and offset mean fewer mood shifts tied to medication cycles.

Side Effects and What to Expect

Strattera has its own side effect profile that patients should understand before starting it.

The most common side effects in the early weeks are nausea and stomach upset, decreased appetite, fatigue, and dry mouth. Nausea is often managed by taking the medication with food. Most gastrointestinal side effects ease after the first few weeks of treatment as the body adjusts.

Adults sometimes experience sexual side effects, including decreased libido or erectile difficulties. Increased heart rate and blood pressure can also occur and are worth monitoring, particularly in people with pre-existing cardiovascular concerns.

A rare but serious concern: Strattera carries an FDA black box warning about increased suicidal thinking in children and adolescents during the first months of treatment. This is the same warning applied to antidepressants. It doesn't mean Strattera causes suicidal behavior, but it does mean close monitoring is important when starting the medication in younger patients.

Liver problems are very rare but have been reported. Signs of liver issues (jaundice, abdominal pain, dark urine) should be reported to a doctor immediately if they occur.

Strattera in Combination Therapy

Some patients and physicians use Strattera in combination with a stimulant medication rather than as a standalone treatment. The rationale: covering both dopamine and norepinephrine pathways may provide better symptom control than either medication alone, while allowing a lower stimulant dose that produces fewer side effects.

This approach works for some people, particularly those whose stimulant coverage doesn't last through the evening or who have specific symptom domains (emotional regulation, anxiety, sustained attention) that respond better to norepinephrine support. A physician prescribing this combination should monitor cardiovascular effects, since both medications can affect heart rate and blood pressure.

Managing ADHD Daily Alongside Medication

Whether you're on Strattera, stimulants, or both, medication manages the neurobiology, but daily structure matters just as much for outcomes. People with ADHD often do their best work when their environment and schedule are designed to reduce friction, not when they're relying on willpower alone. ADHD strategies for adults consistently point to external structure as a key factor.

Lifestack fits well into an ADHD management routine because it auto-schedules tasks around your energy, not just your calendar availability. Instead of relying on you to remember when your focus is sharpest, it maps work to the times you're actually capable of deep concentration. This is particularly relevant when you're managing motivation fluctuations that medication doesn't fully smooth out. The app integrates with Google Calendar and your task list, and works on iOS, Android, and Chrome. Pricing: $7/month or $50/year, with a 7-day free trial.

Medication addresses the underlying neurobiology. Structure addresses the daily reality. Energy-based task management for ADHD and the right medication together tend to produce better outcomes than either approach alone.

If you're also curious about non-medication approaches, our roundup of natural remedies for ADHD in adults covers what the research actually supports, and the ADHD hacks that work guide has practical daily tactics. For deeper focus strategies, see how to focus with ADHD.

Frequently Asked Questions

Is Strattera a stimulant?

No. Strattera (atomoxetine) is a non-stimulant ADHD medication. It works by inhibiting norepinephrine reuptake rather than by increasing dopamine activity the way stimulants like Adderall and Ritalin do. It is not a controlled substance and has no abuse potential.

How long does Strattera take to work?

Most people begin to notice effects after two to four weeks. Full therapeutic benefit typically takes six to eight weeks. This is much slower than stimulants, which work within 30 to 60 minutes of a dose. Patience with the titration period is important when starting Strattera.

Can Strattera be taken with other ADHD medications?

Yes, combination therapy with a stimulant is used by some patients and physicians. The rationale is that Strattera addresses norepinephrine pathways while stimulants address dopamine, potentially providing broader symptom coverage. This requires physician oversight, particularly for cardiovascular monitoring.

Does Strattera help anxiety?

Strattera doesn't worsen anxiety the way stimulants sometimes do, and some patients report mild anxiety reduction alongside ADHD improvement. It's not an anxiety medication, and the evidence is mixed, but for people with both ADHD and anxiety, it's often considered before stimulants for this reason.

What is the standard dose of Strattera for adults?

Dosing is typically based on body weight. For adults, the starting dose is usually 40mg daily, titrated up to 80-100mg over several weeks depending on response and tolerability. The maximum approved dose for adults is 100mg per day. Always follow your prescribing physician's instructions.

Can Strattera cause weight loss?

Strattera can decrease appetite, which may lead to some weight loss, particularly in the early weeks of treatment. This is less pronounced than with stimulant medications for most adults, but it's worth monitoring, especially in children and adolescents who are still growing.